Home Funding NYC-based ByHeart Secures $95Million in Funding

[Funding News] NYC-based ByHeart Secures $95Million in Funding

0
ByHeart, a infant nutrition company, secures $95million in funding. They raised a total of $395M to date from investors including D1 Capital Partners, Bellco Capital, Polaris Partners, Two River, OCV Partners, AF Ventures, Red Sea Ventures, Gaingels and more.
ByHeart, a infant nutrition company, secures $95million in funding. They raised a total of $395M to date from investors including D1 Capital Partners, Bellco Capital, Polaris Partners, Two River, OCV Partners, AF Ventures, Red Sea Ventures, Gaingels and more.
ByHeart, a infant nutrition company, secures $95million in funding. They raised a total of $395M to date from investors including D1 Capital Partners, Bellco Capital, Polaris Partners, Two River, OCV Partners, AF Ventures, Red Sea Ventures, Gaingels and more.

ByHeart, a infant nutrition company, secures $95million in funding. They raised a total of $395M to date from investors including D1 Capital Partners, Bellco Capital, Polaris Partners, Two River, OCV Partners, AF Ventures, Red Sea Ventures, Gaingels and more.

The money will go towards the company’s ongoing US commercial launch as well as the expansion of its innovation pipeline.

It is a baby nourishment firm managed by CEO Ron Belldegrun. It has been certified as a Clean Label Project brand three times. Its end-to-end manufacturing facilities provide it complete control over the production process and guarantee that all quality criteria are met.

ByHeart uses the science of breast milk to develop and sell clinically validated products that facilitate better digestion, reduce spitting, produce softer stools, promote more effective weight gain, and improve nutrient absorption.

Read also – [Funding News] MA-based Monitaur Secures $6Million in Series A Round Funding

The firm, which is growing quickly and most recently entered the Thrive Market, has production sites in Pennsylvania, Oregon, and Iowa. ByHeart plans to open up shop at many more locations by the end of 2024, giving parents worldwide easy access to its healthy, scientifically proven formula.

Ron Belldegrun said: “We are committed to doing better for babies and their parents, and that means continued investments into end-to-end manufacturing, scientific advancement and meaningful innovation in an industry that so desperately needed it.”

Amy Schulman said,”Polaris is delighted to continue to support the expansion of ByHeart’s infant-first mission, ByHeart’s Chair of the Board and Managing Partner at Polaris Partners. “In the long-stagnant infant formula space, ByHeart’s evidence-based approach drives innovation to benefit the health and wellness of babies and families. Our investors and team recognize the responsibility we have to provide the highest standard of nutrition, crafted with scientific precision and the utmost care.”

About ByHeart

New York City-based ByHeart , a baby nutrition company that was founded in 2016 and has production facilities in Pennsylvania, Oregon, and Iowa. Its mission is to provide parents more options so they may raise their children in a healthier way. Founded on nutritional excellence and a farm-to-formula verifiedTM quality programme, ByHeart is one of only five fully integrated, FDA-registered baby formula companies in the nation.

Exit mobile version